The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Andrew Kryuchkov
Rapid Ascend: Axonics Gains Ground in the SNM Market Amid F15 Launch and Next-Gen R20 System Arrival
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.